Leslie Harrold to Medication Adherence
This is a "connection" page, showing publications Leslie Harrold has written about Medication Adherence.
Connection Strength
2.660
-
Harrold LR, Stolshek BS, Rebello S, Collier DH, Mutebi A, Wade SW, Malley W, Greenberg JD, Etzel CJ. Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity. J Rheumatol. 2018 01; 45(1):78-82.
Score: 0.484
-
Nasser-Ghodsi N, Harrold LR. Overcoming adherence issues and other barriers to optimal care in gout. Curr Opin Rheumatol. 2015 Mar; 27(2):134-8.
Score: 0.404
-
Harrold LR, Gurwitz JH, Briesacher BA. Dr. Harrold, et al reply. J Rheumatol. 2013 Aug; 40(8):1462.
Score: 0.362
-
Harrold LR, Briesacher BA, Peterson D, Beard A, Madden J, Zhang F, Gurwitz JH, Soumerai SB. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013 Feb; 40(2):137-43.
Score: 0.349
-
Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA. Patients and providers view gout differently: a qualitative study. Chronic Illn. 2010 Dec; 6(4):263-71.
Score: 0.294
-
Zak A, Corrigan C, Yu Z, Bitton A, Fraenkel L, Harrold L, Smolen JS, Solomon DH. Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial. Rheumatology (Oxford). 2018 11 01; 57(11):1933-1937.
Score: 0.130
-
Harrold LR, Reed GW, John A, Barr CJ, Soe K, Magner R, Saunders KC, Ruderman EM, Haselkorn T, Greenberg JD, Gibofsky A, Harrington JT, Kremer JM. Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 03; 70(3):379-387.
Score: 0.124
-
Curtis JR, Bharat A, Chen L, Greenberg JD, Harrold L, Kremer JM, Sommers T, Pappas D. Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry. J Rheumatol. 2016 06; 43(6):1027-9.
Score: 0.110
-
Spruill TM, Ogedegbe G, Harrold LR, Potter J, Scher JU, Rosenthal PB, Greenberg JD. Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African-American rheumatoid arthritis patients. Ann Rheum Dis. 2014 Jan; 73(1):317-8.
Score: 0.091
-
Rathbun AM, Reed GW, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology (Oxford). 2013 Oct; 52(10):1785-94.
Score: 0.087
-
Nitichaikulvatana P, Upchurch KS, Harrold LR. Impact of deficits in gout care on hospitalizations. J Clin Rheumatol. 2011 Oct; 17(7):389-91.
Score: 0.080
-
Briesacher BA, Andrade SE, Harrold LR, Fouayzi H, Yood RA. Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates. Pharmacoepidemiol Drug Saf. 2010 Dec; 19(12):1233-40.
Score: 0.075
-
Briesacher BA, Andrade SE, Harrold LR, Fouayzi H, Yood RA. Adoption of once-monthly oral bisphosphonates and the impact on adherence. Am J Med. 2010 Mar; 123(3):275-80.
Score: 0.071